Dermal endothelial cells and keratinocytes produce IL-7 in vivo after human Schistosoma mansoni percutaneous infection.
暂无分享,去创建一个
J. Cesbron | F. Remoue | N. Delhem | F. Trottein | C. Auriault | V. Martinot | I. Wolowczuk | M. Delacre | S. Nutten | J. Decavel | O. Roye
[1] B. Autran,et al. Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin. , 1998, Journal of immunology.
[2] Kenneth M. Yamada,et al. Induction of T cell adhesion to extracellular matrix or endothelial cell ligands by soluble or matrix‐bound interleukin‐7 , 1997, European journal of immunology.
[3] T. Kupper,et al. IL-7 overexpression in transgenic mouse keratinocytes causes a lymphoproliferative skin disease dominated by intermediate TCR cells: evidence for a hierarchy in IL-7 responsiveness among cutaneous T cells. , 1997, Journal of immunology.
[4] C. Carini,et al. Modulation of TCR usage in HIV-1 infection is regulated by IL-7 and sCD23. , 1997, Allergologia et immunopathologia.
[5] G. Soslau,et al. Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function. , 1997, Cytokine.
[6] C. Auriault,et al. Interleukin‐7 in the skin of Schistosoma mansoni‐infected mice is associated with a decrease in interferon‐γ production and leads to an aggravation of the disease , 1997, Immunology.
[7] A. Mantovani,et al. Cytokine regulation of endothelial cell function: from molecular level to the bedside. , 1997, Immunology today.
[8] F. Pimpinelli,et al. Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaque-type psoriasis. , 1997, Clinical immunology and immunopathology.
[9] Bos Jd. The skin as an organ of immunity , 1997 .
[10] H. Nakagawa,et al. Changes in eosinophil and leukocyte infiltration and expression of IL-6 and IL-7 messenger RNA in mite allergen patch test reactions in atopic dermatitis. , 1996, The Journal of allergy and clinical immunology.
[11] C. Carini,et al. Interleukin-7 modulates intracytoplasmatic CD23 production and induces adhesion molecule expression and adhesiveness in activated CD4+CD23+ T cell subsets. , 1996, Clinical immunology and immunopathology.
[12] M. Monsigny,et al. Selective induction of peripheral and mucosal endothelial cell addressins with peripheral lymph nodes and Peyer's patch cell‐conditioned media , 1996, Journal of leukocyte biology.
[13] B. Nickoloff,et al. Dermal injection of immunocytes induces psoriasis. , 1996, The Journal of clinical investigation.
[14] K. Ley,et al. Molecular mechanisms of leukocyte recruitment in the inflammatory process. , 1996, Cardiovascular research.
[15] J. Gerdes,et al. Human follicular dendritic cells and vascular cells produce interleukin‐7: a potential role for interleukin‐7 in the germinal center reaction , 1996, European journal of immunology.
[16] D. Rollinson,et al. Royal Society of Tropical Medicine and Hygiene meeting at Manson House, London, 18 May 1995. The epidemiology of human schistosomiasis in the Senegal river basin. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[17] D. Schadendorf,et al. Interleukin‐7. Biology and implications for dermatology , 1996, Experimental dermatology.
[18] E. E. Max,et al. Infection of human endothelial cells with Epstein-Barr virus , 1995, The Journal of experimental medicine.
[19] J. Siegel,et al. Synergistic effects of IL-7 and IL-12 on human T cell activation. , 1995, Journal of immunology.
[20] F. Lowy,et al. Internalization of Staphylococcus aureus by endothelial cells induces cytokine gene expression , 1995, Infection and immunity.
[21] S. Burdach,et al. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.
[22] B. Nickoloff,et al. IL-7 in the cell-mediated immune response to a human pathogen. , 1995, Journal of immunology.
[23] T. Edgington,et al. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. , 1994, Blood.
[24] I. Shih,et al. Development of pemphigus vulgaris-like lesions in severe combined immunodeficiency disease mice reconstituted with lymphocytes from patients. , 1993, The Journal of clinical investigation.
[25] G. Schuler,et al. Interleukin 7 is produced by murine and human keratinocytes , 1993, The Journal of experimental medicine.
[26] D. Olive,et al. Interleukin-7, a major T-lymphocyte cytokine. , 1993, European cytokine network.
[27] M. Herlyn,et al. Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. , 1993, The Journal of clinical investigation.
[28] F. Auger,et al. Comparative epidermal Langerhans cell migration studies in epidermal and epidermal/dermal equivalent grafts. , 1992, The Journal of investigative dermatology.
[29] A. Kongs,et al. Preliminary study of the prevalence of human schistosomiasis in Richard-Toll (the Senegal river basin). , 1992, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[30] E. Bauer,et al. Recessive dystrophic epidermolysis bullosa phenotype is preserved in xenografts using SCID mice: development of an experimental in vivo model. , 1992, The Journal of investigative dermatology.
[31] L. Abel,et al. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. , 1991, American journal of human genetics.
[32] L. Picker,et al. A unique phenotype of skin-associated lymphocytes in humans. Preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. , 1990, The American journal of pathology.
[33] R. Armitage,et al. Human IL-7: a novel T cell growth factor. , 1989, Journal of immunology.
[34] G. Krueger,et al. Immunology/inflammation of the skin--a 50-year perspective. , 1989, The Journal of investigative dermatology.
[35] H. A. Wilkins. Reinfection after treatment of schistosome infections. , 1989, Parasitology today.
[36] A. Prata,et al. Human resistance to Schistosoma mansoni is associated with IgG reactivity to a 37-kDa larval surface antigen. , 1988, Journal of immunology.
[37] C. March,et al. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors , 1988, The Journal of experimental medicine.
[38] S. R. Smithers,et al. IMMUNITY IN SCHISTOSOMIASIS , 1969, Lancet.
[39] J. S. Cordingley,et al. Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[40] J. Streilein. Skin-associated lymphoid tissues (SALT): origins and functions. , 1983, The Journal of investigative dermatology.
[41] R. Wilson,et al. An examination of the skin phase of schistosome migration using a hamster cheek pouch preparation , 1980, Parasitology.
[42] R. Wilson,et al. Schistosoma mansoni: a histological study of migration in the laboratory mouse , 1979, Parasitology.
[43] R. Wilson,et al. Migration of the schistosomula of Schistosoma mansoni from skin to lungs , 1978, Parasitology.
[44] M. Taylor,et al. Transformation of cercariae to schistosomula: A quantitative comparison of transformation techniques and of infectivity by different injection routes of the organisms produced , 1976, Journal of Helminthology.
[45] N Katz,et al. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. , 1972, Revista do Instituto de Medicina Tropical de Sao Paulo.